Novozymes A/S (OTCMKTS:NVZMY) Share Price Passes Above Fifty Day Moving Average – Should You Sell?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report)’s share price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $56.71 and traded as high as $56.94. Novozymes A/S shares last traded at $56.06, with a volume of 14,651 shares traded.

Analysts Set New Price Targets

Separately, Barclays upgraded shares of Novozymes A/S to a “strong-buy” rating in a research note on Monday, November 18th.

Check Out Our Latest Stock Report on Novozymes A/S

Novozymes A/S Stock Performance

The firm has a market capitalization of $26.25 billion, a P/E ratio of 35.48, a price-to-earnings-growth ratio of 3.87 and a beta of 0.88. The business has a 50 day simple moving average of $56.71 and a two-hundred day simple moving average of $61.82.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Further Reading

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.